Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents
Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents
复制标题
DOI:
10.1016/j.bmcl.2006.01.027
复制
发表时间:
2006-04-15
影响因子:
2.7
通讯作者:
Becker, K
中科院分区:
文献类型:
--
作者:
Andricopulo, AD;Akoachere, MB;Becker, K
Plasmodium falciparum thioredoxin reductase (PfTrxR:NADPH+Trx(S)(2)+H+ NADP(+)+Trx(SH)(2)) is a high M-r flavin-dependent TrxR that reduces thioredoxin (Trx) via a CysXXXXCys pair located penultimately to the C-terminal Gly. In this respect, PfTrxR differs significantly from its human counterpart which bears a Cys-Sec redox pair at the same position. PfTrxR is essentially involved in antioxidant defense and redox regulation of the parasite and has been previously validated by knock-out studies as a potential drug target for malaria chemotherapy. Moreover, human TrxR is present in most cancer cells at levels tenfold higher than in normal cells. Here we report the discovery of a series of potent inhibitors of PfTrxR. The three most promising inhibitors, 3 (IC50PfTrxR=2 mu M and IC50hTrxR=50 mu M), 7 (IC50PfTrxR=2 mu M and IC50hTrxR=140 mu M), and 11 (IC50PfTrxR=0.5 mu M and IC50hTrxR=4 mu M) were selective for the parasite enzyme. Detailed mechanistic characterization of the effects of these compounds on the PfTrxR-catalyzed reaction showed clear uncompetitive inhibition with respect to both substrate and cofactor. For the most specific PfTrxR inhibitor 7, an alkylation mechanism study based oil a thiol conjugation model was performed. Furthermore, all three compounds were active in the lower micromolar range on the chloroquine-resistant P. falciparum strain K1 in vitro. (C) 2006 Elsevier Ltd. All rights reserved.